Literature DB >> 18951063

Transfusion medicine in a developing country - alloantibodies to red blood cells in multi-transfused patients in Saudi Arabia.

Abdel Galil M Abdel Gader1, Abeer K Al Ghumlas, Abdel Kareem M Al-Momen.   

Abstract

BACKGROUND: Multiple transfusions are frequently complicated by alloimmunization. This retrospective study aims to determine whether alloimmunization could be accounted for by racial differences between donors and recipients.
MATERIALS AND METHODS: The development of alloantibodies were determined in 68 multi-transfused patients (thalassaemia, n=38) and (sickle cell anemia, n=30).
RESULTS: The overall frequency of alloantibody formation in our patients is 22.06%. Thirteen patients received blood from the same ethnic group (Arab) and none developed antibodies, while of 47 patients who received multi-ethnic blood, 10 developed alloantibodies.
CONCLUSIONS: Alloantibodies formation can be reduced by limiting the transfusion of RBC, collected from donors of the same ethnic origin.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18951063     DOI: 10.1016/j.transci.2008.09.013

Source DB:  PubMed          Journal:  Transfus Apher Sci        ISSN: 1473-0502            Impact factor:   1.764


  7 in total

1.  Frequency of RBC Alloantibodies in Chinese Surgical Patients.

Authors:  Qiushi Wang; Qiaoni Yang; Yingzhe Bai; Chengxin Zhang; Yanni Diao; Deqiang Fang
Journal:  Transfus Med Hemother       Date:  2012-07-05       Impact factor: 3.747

2.  Red cell alloimmunization and autoantibodies in Egyptian transfusion-dependent thalassaemia patients.

Authors:  Azza Mohamed Ahmed; Nehal Salah Hasan; Shadia Hassan Ragab; Sonia Adolf Habib; Nahed Abdelmonem Emara; Azza Ahmed Aly
Journal:  Arch Med Sci       Date:  2010-09-07       Impact factor: 3.318

3.  Frequency of Red Cell Alloimmunization and Autoimmunization in Thalassemia Patients: A Report from Eastern India.

Authors:  Suvro Sankha Datta; Somnath Mukherjee; Biplabendu Talukder; Prasun Bhattacharya; Krishnendu Mukherjee
Journal:  Adv Hematol       Date:  2015-09-06

4.  Alloimmunization in Patients with Sickle Cell Disease and Thalassemia: Experience of a Single Centre in Oman.

Authors:  Salam Alkindi; Saba AlMahrooqi; Sumaiya AlHinai; Ali AlMarhoobi; Saif Al-Hosni; Shahina Daar; Naglaa Fawaz; Anil Pathare
Journal:  Mediterr J Hematol Infect Dis       Date:  2017-02-15       Impact factor: 2.576

5.  A study of red blood cell alloimmunization and autoimmunization among 200 multitransfused Egyptian β thalassemia patients.

Authors:  Amal El-Beshlawy; Alshymaa Ahmed Salama; Mohamed Roshdy El-Masry; Noha M El Husseiny; Asmaa M Abdelhameed
Journal:  Sci Rep       Date:  2020-12-03       Impact factor: 4.379

6.  Beta thalassemia major in a developing country: epidemiological, clinical and evolutionary aspects.

Authors:  Mohamed Bejaoui; Naouel Guirat
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-01-02       Impact factor: 2.576

7.  Study of Frequency and Characteristics of Red Blood Cell Alloimmunization in Thalassemic Patients: Multicenter Study from Palestine.

Authors:  Adham Abu Taha; Ahmad Yaseen; Sa'd Suleiman; Omar Abu Zenah; Hammam Ali; Rania Abu Seir; Khaled Younis
Journal:  Adv Hematol       Date:  2019-11-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.